Alteron Therapeutics
Kalamazoo · Founded 2017
About Alteron Therapeutics
Alteron Therapeutic is pharmaceutical startup dedicated to developing innovative drugs for the treatment Alzheimer's disease (AD) and Amyotrophic Lateral Sclerosis (ALS). We target high TDP-43 activity, which is the root cause of neuronal death. By inhibiting TDP-43, out drugs can simultaneously eliminate the three pathological markers of neurodegeneration and their efficacy has been verified in an hTDP-43 transgenic mouse disease model.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Seed (Aug 2020)
- Website: https://alterontherapeutics.com/
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/alteron-therapeutics-2457700 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.